Latest News Archive

Please select Category, Year, and then Month to display items
Years
2019 2020 2021 2024
Previous Archive
19 March 2019 | Story Dr Cinde Greyling
Dr Mutana and Prof Mukwada
Many people enjoy spending time in the mountainous Drakensberg region. Prof Geofrey Mukwada’s involvement with the UFS Afromontane Research Unit (ARU) sparked an interest in sustainable tourism in the area. Pictured here are Dr Sarudzai Mutana with Prof Mukwada.

Not only is the Qwaqwa Campus situated in a beautiful region – its researchers also contribute to keeping the area pristine. Recent research by Prof Geofrey Mukwada and his PhD student, Dr Sarudzai Mutana, focused on indicators monitoring sustainable tourism development in the Drakensberg region.

Dr Mukwada is an Associate Professor in the Department of Geography on the University of the Free State (UFS) Qwaqwa Campus. 

Our majestic mountains are fragile

Many people enjoy spending time in the mountainous Drakensberg region – either as adventure seekers exploring the many trails, or just relaxing and reconnecting with nature. Prof Mukwada’s involvement with the UFS Afromontane Research Unit (ARU) sparked an interest in sustainable tourism in the area. “Mountains are fragile but attractive environments which continue to attract tourists,” he said. “Tourism is one of the major business sectors in the Drakensberg region, with promising growth opportunities and proving to be an anchor of green economy in the future – if practiced correctly.” Unfortunately, the issue of monitoring sustainable tourism has not been widely researched in African mountains. 

According to international standards

“We specifically looked at the Global Sustainable Tourism Criteria (GSTC), which is an international best-practice framework to help destinations monitor and ensure that tourism is developed in a responsible manner,” Prof Mukwada explained. “South Africa’s Manual for Responsible Tourism was designed according to some of the recommendations of the GSTC. But we found that, while the tourism and hospitality operators in the Drakensberg region appreciates the need to monitor and ensure sustainable tourism in the area, there is limited use of indicators as a tool for monitoring.” 

Forward together

There are competing demands between land-use and development practices and alternatives in the region – unless the focus shifts to sustainable practices, the short-term gains could be followed by dire consequences. “We suggest an integrated monitoring of tourism development, with a pro-poor focus that involves more local community leaders. Going forward, we would like to see the industry adopt the indicators proposed in our study.”

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept